Search results for the GEO ID: GSE29828
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM739148
GPL570
3 uM EPZ004777 treated, DAY 2, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 2 biological rep: 1 Gene expression data from 3 uM EPZ004777 treated, DAY 2, biological rep.1, MV4-11 cells
GSM739149
GPL570
3 uM EPZ004777 treated, DAY 2, biological rep.2, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 2 biological rep: 2 Gene expression data from 3 uM EPZ004777 treated, DAY 2, biological rep.2, MV4-11 cells
GSM739150
GPL570
3 uM EPZ004777 treated, DAY 2, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 2 biological rep: 3 Gene expression data from 3 uM EPZ004777 treated, DAY 2, biological rep.3, MV4-11 cells
GSM739151
GPL570
Vehicle treated, DAY 2, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 2 biological rep: 1 Gene expression data from Vehicle treated, DAY 2, biological rep.1, MV4-11 cells
GSM739152
GPL570
Vehicle treated, DAY 2, biological rep.2, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 2 biological rep: 2 Gene expression data from Vehicle treated, DAY 2, biological rep.2, MV4-11 cells
GSM739153
GPL570
Vehicle treated, DAY 2, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 2 biological rep: 3 Gene expression data from Vehicle treated, DAY 2, biological rep.3, MV4-11 cells
GSM739154
GPL570
3 uM EPZ004777 treated, DAY 4, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 4 biological rep: 1 Gene expression data from 3 uM EPZ004777 treated, DAY 4, biological rep.1, MV4-11 cells
GSM739155
GPL570
3 uM EPZ004777 treated, DAY 4, biological rep.2, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 4 biological rep: 2 Gene expression data from 3 uM EPZ004777 treated, DAY 4, biological rep.2, MV4-11 cells
GSM739156
GPL570
3 uM EPZ004777 treated, DAY 4, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 4 biological rep: 3 Gene expression data from 3 uM EPZ004777 treated, DAY 4, biological rep.3, MV4-11 cells
GSM739157
GPL570
Vehicle treated, DAY 4, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 4 biological rep: 1 Gene expression data from Vehicle treated, DAY 4, biological rep.1, MV4-11 cells
GSM739159
GPL570
Vehicle treated, DAY 4, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 4 biological rep: 3 Gene expression data from Vehicle treated, DAY 4, biological rep.3, MV4-11 cells
GSM739160
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 6 biological rep: 1 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.1, MV4-11 cells
GSM739161
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.2, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 6 biological rep: 2 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.2, MV4-11 cells
GSM739162
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: EPZ004777 time: day 6 biological rep: 3 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.3, MV4-11 cells
GSM739163
GPL570
Vehicle treated, DAY 6, biological rep.1, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 6 biological rep: 1 Gene expression data from Vehicle treated, DAY 6, biological rep.1, MV4-11 cells
GSM739164
GPL570
Vehicle treated, DAY 6, biological rep.2, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 6 biological rep: 2 Gene expression data from Vehicle treated, DAY 6, biological rep.2, MV4-11 cells
GSM739165
GPL570
Vehicle treated, DAY 6, biological rep.3, MV4-11 cells MV4-11 cells cell line: MV4-11 cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment) growth conditions: IMDM with 10% FBS agent: Vehicle time: day 6 biological rep: 3 Gene expression data from Vehicle treated, DAY 6, biological rep.3, MV4-11 cells
GSM739166
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.1, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: EPZ004777 time: day 6 biological rep: 1 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.1, MOLM-13 cells
GSM739167
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.2, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: EPZ004777 time: day 6 biological rep: 2 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.2, MOLM-13 cells
GSM739168
GPL570
3 uM EPZ004777 treated, DAY 6, biological rep.3, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: EPZ004777 time: day 6 biological rep: 3 Gene expression data from 3 uM EPZ004777 treated, DAY 6, biological rep.3, MOLM-13 cells
GSM739169
GPL570
Vehicle treated, DAY 6, biological rep.1, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: Vehicle time: day 6 biological rep: 1 Gene expression data from Vehicle treated, DAY 6, biological rep.1, MOLM-13 cells
GSM739170
GPL570
Vehicle treated, DAY 6, biological rep.2, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: Vehicle time: day 6 biological rep: 2 Gene expression data from Vehicle treated, DAY 6, biological rep.2, MOLM-13 cells
GSM739171
GPL570
Vehicle treated, DAY 6, biological rep.3, MOLM-13 cells MOLM-13 cells cell line: MOLM-13 cell line description: acute myeloid leukemia (MLL-AF9 rearrangement) growth conditions: RPMI with 10% FBS agent: Vehicle time: day 6 biological rep: 3 Gene expression data from Vehicle treated, DAY 6, biological rep.3, MOLM-13 cells
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes